Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding off-target effects, immune activation, and unnecessary drug exposure. (Nanowerk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback